Condensed Consolidated Statements of Income - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
REVENUE:
Total revenue	$ 1,849.6	$ 1,539.7
COST OF REVENUE:
Total cost of revenue	364.5	293.1
GROSS PROFIT:
Total gross profit	1,485.1	1,246.6
OPERATING EXPENSES:
Research and development	214.0	198.6
Sales and marketing	636.3	542.7
General and administrative	56.2	57.8
Gain on intellectual property matters	(1.4)	(6.3)
Total operating expenses	905.1	792.8
OPERATING INCOME	580.0	453.8
INTEREST INCOME	32.9	44.3
INTEREST EXPENSE	(4.2)	(4.9)
OTHER INCOME—NET	47.9	26.1
INCOME BEFORE INCOME TAXES AND GAIN (LOSS) FROM EQUITY METHOD INVESTMENTS	656.6	519.3
PROVISION FOR INCOME TAXES	122.0	96.5
GAIN (LOSS) FROM EQUITY METHOD INVESTMENTS	(0.1)	10.6
NET INCOME	$ 534.5	$ 433.4
Net income per share:
Basic (in dollars per share)	$ 0.72	$ 0.56
Diluted (in dollars per share)	$ 0.72	$ 0.56
Weighted-average shares outstanding:
Basic (in shares)	738.8	768.3
Diluted (in shares)	742.8	776.8
Product
REVENUE:
Total revenue	$ 645.1	$ 459.1
COST OF REVENUE:
Total cost of revenue	208.3	149.9
GROSS PROFIT:
Total gross profit	436.8	309.2
Service
REVENUE:
Total revenue	1,204.5	1,080.6
COST OF REVENUE:
Total cost of revenue	156.2	143.2
GROSS PROFIT:
Total gross profit	$ 1,048.3	$ 937.4